CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News

from Stock Movers · host iHeartPodcasts

On this episode of Stock Movers:- CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion.- Mankind (MNKD) shares rise after the FDA approved an update to the company’s inhaled insulin, revising recommendations for the starting mealtime dosage.- Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.See omnystudio.com/listener for privacy information.

NOW PLAYING

0:00 2:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stock Movers?

This episode is 2 minutes long.

When was this Stock Movers episode published?

This episode was published on January 26, 2026.

What is this episode about?

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Stock Movers episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!